Siemens' SARS-CoV-2 test measures neutralizing antibodies

By staff writers

November 18, 2020 -- Siemens Healthineers has announced that its SARS-CoV-2 immunoglobin G (IgG) antibody test (sCOVG) is able to measure neutralizing antibodies for the virus.

The SARS-CoV-2 IgG antibody test is an enhanced version of the assay that became available globally during the summer and can detect neutralizing antibodies and report quantitative results measuring the amounts of neutralizing antibodies present in a patient's blood sample. Fully automated antibody tests like this can be used to help determine whether broad vaccination programs are working, according to the company.

The test has been granted a CE Mark, and Siemens has applied to the U.S. Food and Drug Administration for an emergency use authorization.

Siemens Healthineers posts dip in Q4 revenues
Siemens Healthineers posted a 2% decline in revenues for the company's fourth quarter of fiscal 2020. Net income also slipped for the period, but the...
Siemens donates $500K to Testing for America
Siemens Healthineers and the Siemens Foundation have partnered with Testing for America to donate $500,000 in funding and COVID-19 testing to historically...
Siemens collaborates with CDC, EC on SARS-CoV-2 assay standards
Siemens Healthineers said that it's collaborating with the U.S. Centers for Disease Control and Prevention (CDC) and the Joint Research Centre of the...
Siemens begins shipping COVID-19 antibody test in Canada
Siemens Healthineers has begun shipping its total antibody test for COVID-19 in Canada. The firm recently received Health Canada Interim Order authorization...
Sysmex America inks distribution deal with Siemens
Sysmex America has secured a contract with Siemens Healthineers to distribute that company's Clinitek Novus automated urine chemistry analyzer in North...

Copyright © 2020

Last Updated bc 11/20/2020 4:30:52 PM

Subscribe Today
Do you want to be a Microbiology Insider?

When LabPulse gets hot new information, our Insiders are the first to find out. Stay current in today's competitive market by receiving our exclusive free email updates.

Yes, Keep Me Current